NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. It offers ExoPTEN, for treatment of acute spinal cord injuries. The company was founded in 2020 and is based in Toronto, Canada.
Frequently asked questions
What sector does NurExone Biologic Inc. (NRX) operate in?
NurExone Biologic Inc. belongs to the Healthcare sector and operates in the Biotechnology industry.
What is NurExone Biologic Inc. (NRX) current stock price?
As of the latest data, NurExone Biologic Inc. stock price is CA$0.48, with a previous close of CA$0.47. NurExone Biologic Inc. gained CA$0.01 in the last trading session, representing a 2.13% increase.
What is NurExone Biologic Inc. (NRX) current market capitalization?
NurExone Biologic Inc. market cap is approximately 44.18 million.
What is NurExone Biologic Inc. (NRX) Earnings Per Share (EPS)?
The trailing EPS is -CA$0.11.
Does NurExone Biologic Inc. (NRX) pay dividends?
No. NurExone Biologic Inc. does not pay a dividend.
When is NurExone Biologic Inc. (NRX) next earnings report?
NurExone Biologic Inc. is expected to release its next earnings report on June 30, 2026.
What is NurExone Biologic Inc. (NRX) beta (volatility) score?
NurExone Biologic Inc. has a beta of 0.387, indicating lower volatility than the overall market.